PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging

Jaideep Sohi, MD, and Jeremie Calais, MD, examine the comparative merits of PSMA PET and Gallium-Based PET while exploring the application of NCCN Guidelines in prostate cancer imaging protocols.

Now Viewing

EP: 1.PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging

EP: 2.Insights into the Benefit of PSMA PET Imaging Alongside Other Conventional Imaging Modalities in Prostate Cancer Care

EP: 3.The Role of PSMA PET in Early Detection and Prostate Cancer Staging

EP: 4.Understanding Oligometastatic Disease in Prostate Cancer: Insights from PSMA PET Imaging

Video content above is prompted by the following:

• What are the NCCN Guidelines' recommendations for gallium-based versus non-gallium-based PET agents in prostate cancer imaging, and how does PSMA PET imaging impact prostate cancer care in your view?

Recent Videos